Prescription drug · ANDA
Niacin NDC 68180-222
Niacin 750 mg/1 · Tablet, Extended release · Oral · Lupin Pharmaceuticals, Inc.
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Niacin
- Generic name (nonproprietary)
- niacin
- Active ingredients
- Niacin — 750 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Lupin Pharmaceuticals, Inc.NDC labeler code 68180
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090892
- Marketing start
- Listing expires
- Other FDA classes
- Nicotinic Acids (Chemical structure)
- Identifiers
- Product ID 68180-222_309a40e8-333f-478a-8a94-beff7f3ca5b2SPL ID 309a40e8-333f-478a-8a94-beff7f3ca5b2SPL set ID 92b3ec1d-0dc7-4bde-9817-57b1bdf7f0b9RxCUI 1098134, 1098141, 1098143UNII 2679MF687A
- Pharmacologic class
- Nicotinic Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Niacin extended-release tablet USP contains extended-release niacin (nicotinic acid), and is indicated: • To reduce elevated TC, LDL-C, Apo B and TG, and to increase HDL-C in patients with primary hyperlipidemia and mixed dyslipidemia. ( 1 ) • To reduce the risk of recurrent nonfatal myocardial infarction in patients with a history of myocardial infarction and hyperlipidemia. ( 1 ) • In combination with a bile acid binding resin : Slows progression or promotes regression of atherosclerotic disease in patients with a history of coronary artery disease (CAD) and hyperlipidemia. ( 1 ) As an adjunct to diet to reduce elevated TC and LDL-C in adult patients with primary hyperlipidemia. ( 1 ) • To…
Excerpt only. Read the full label for complete information.
About NDC 68180-222
- What is NDC 68180-222?
- 68180-222 is the product NDC for Niacin, Niacin 750 mg/1 tablet, extended release, listed with the FDA by Lupin Pharmaceuticals, Inc..
- What drug is associated with this NDC?
- Niacin.
- What is the active ingredient?
- Niacin.
- Who is the labeler?
- Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Niacin?
- 22 other product NDCs are listed under this name. See all Niacin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Niacin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Niacin | Niacin 500 mg/1 | Tablet, Extended releaseOral | QUAGEN PHARMACEUTICALS LLC | 70752-295 | 70752-0295-09 |
| Niacin | Niacin 1000 mg/1 | Tablet, Extended releaseOral | QUAGEN PHARMACEUTICALS LLC | 70752-296 | 70752-0296-09 |
| Niacin | Niacin 500 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-187 | 33342-0187-1033342-0187-11 |
| Niacin | Niacin 1000 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | 33342-189 | 33342-0189-1033342-0189-11 |
| Niacin | Niacin 750 mg/1 | Tablet, Extended releaseOral | Aurobindo Pharma Limited | 59651-019 | 59651-0019-0559651-0019-1859651-0019-90 |
| Niacin | Niacin 1000 mg/1 | Tablet, Extended releaseOral | Aurobindo Pharma Limited | 59651-020 | 59651-0020-0559651-0020-1859651-0020-90 |
| Niacin | Niacin 500 mg/1 | Tablet, Extended releaseOral | Aurobindo Pharma Limited | 59651-018 | 59651-0018-0559651-0018-1859651-0018-90 |
| Niacin | Niacin 500 mg/1 | Tablet, Extended releaseOral | AvPAK | 50268-584 | 50268-0584-13 |
| Niacin | Niacin 1000 mg/1 | Tablet, Extended releaseOral | Golden State Medical Supply, Inc. | 51407-268 | 51407-0268-90 |
| Niacin | Niacin 500 mg/1 | Tablet, Extended releaseOral | Golden State Medical Supply, Inc. | 51407-267 | 51407-0267-90 |